Combined Therapies of Bone Disease with Bisphosphonates

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|27|2988-2997

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.27, 2010-09, pp. : 2988-2997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease

By Dawson Nancy A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite

Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease

By Bobba Raja S.  

Drug Safety, Vol. 29, Iss. 12, 2006-01 ,pp. : 1133-1152

Adis International

Access to resources Recommend Favorite

Bisphosphonates as Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1262-1271

Bentham Science Publishers

Access to resources Recommend Favorite

State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents

By  

Current Pharmaceutical Analysis, Vol. 1, Iss. 3, 2005-11 ,pp. : 225-241

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 11, 2016-03 ,pp. : 1546-1557

Bentham Science Publishers

Access to resources Recommend Favorite